Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$209.01 - $232.56 $4,807 - $5,348
23 Added 0.84%
2,757 $602,000
Q4 2023

Feb 06, 2024

SELL
$197.69 - $227.29 $1,383 - $1,591
-7 Reduced 0.26%
2,734 $621,000
Q3 2023

Oct 27, 2023

SELL
$201.05 - $221.7 $20,507 - $22,613
-102 Reduced 3.59%
2,741 $551,000
Q2 2023

Aug 03, 2023

BUY
$211.93 - $241.33 $9,960 - $11,342
47 Added 1.68%
2,843 $686,000
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $80,208 - $96,944
376 Added 15.54%
2,796 $641,000
Q4 2022

Feb 10, 2023

SELL
$203.72 - $248.97 $3,259 - $3,983
-16 Reduced 0.66%
2,420 $569,000
Q3 2022

Nov 09, 2022

SELL
$204.81 - $262.19 $44,853 - $57,419
-219 Reduced 8.25%
2,436 $499,000
Q2 2022

Aug 02, 2022

BUY
$213.86 - $277.87 $16,039 - $20,840
75 Added 2.91%
2,655 $622,000
Q1 2022

May 10, 2022

SELL
$259.82 - $298.18 $15,329 - $17,592
-59 Reduced 2.24%
2,580 $680,000
Q4 2021

Feb 09, 2022

SELL
$271.6 - $314.21 $87,183 - $100,861
-321 Reduced 10.84%
2,639 $829,000
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $9,343 - $10,483
-34 Reduced 1.14%
2,960 $833,000
Q3 2021

Nov 09, 2021

BUY
$274.82 - $308.34 $23,359 - $26,208
85 Added 2.92%
2,994 $842,000
Q2 2021

Aug 09, 2021

SELL
$251.87 - $278.14 $251 - $278
-1 Reduced 0.03%
2,909 $802,000
Q1 2021

May 11, 2021

BUY
$204.88 - $255.03 $97,932 - $121,904
478 Added 19.65%
2,910 $742,000
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $6,354 - $7,290
34 Added 1.42%
2,432 $495,000
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $4,509 - $5,435
-27 Reduced 1.11%
2,398 $451,000
Q2 2020

Jul 31, 2020

SELL
$113.31 - $182.44 $49,403 - $79,543
-436 Reduced 15.24%
2,425 $402,000
Q1 2020

May 05, 2020

BUY
$104.32 - $195.28 $252,975 - $473,554
2,425 Added 556.19%
2,861 $361,000
Q3 2019

Oct 23, 2019

SELL
$159.77 - $178.1 $479 - $534
-3 Reduced 0.68%
436 $73,000
Q2 2019

Aug 05, 2019

SELL
$144.16 - $172.9 $3,315 - $3,976
-23 Reduced 4.98%
439 $0
Q1 2019

Apr 26, 2019

SELL
$123.7 - $156.3 $1,113 - $1,406
-9 Reduced 1.91%
462 $0
Q4 2018

Feb 11, 2019

SELL
$120.82 - $174.09 $5,316 - $7,659
-44 Reduced 8.54%
471 $59,000
Q3 2018

Nov 05, 2018

BUY
$167.67 - $188.27 $75,786 - $85,098
452 Added 717.46%
515 $0
Q3 2018

Nov 05, 2018

SELL
$167.67 - $188.27 $79,475 - $89,239
-474 Reduced 88.27%
63 $0
Q2 2018

Aug 07, 2018

SELL
$160.33 - $189.41 $1,122 - $1,325
-7 Reduced 1.29%
537 $0
Q1 2018

May 02, 2018

BUY
$161.53 - $178.11 $3,876 - $4,274
24 Added 4.62%
544 $0
Q4 2017

Jan 25, 2018

BUY
$147.99 - $163.95 $63,487 - $70,334
429 Added 471.43%
520 $0
Q3 2017

Nov 09, 2017

SELL
$149.47 - $160.56 $448 - $481
-3 Reduced 3.19%
91 $0
Q2 2017

Aug 14, 2017

BUY
N/A
94
94 $0

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.